Sasol – Pharma Excipients Division
Sasol is a global integrated chemicals and energy company headquartered in South Africa. Its pharma excipients division produces high‑purity polyethylene glycols (LIPOXOL MED), fatty alcohols and specialty bases that enhance stability, solubility and bioavailability in pharmaceutical formulations. These excipients meet pharmacopoeial standards and are used in ointments, creams, tablets and suppositories. Sasol’s technical expertise and global footprint allow it to support customers worldwide.
- Company Snapshot: Sasol’s pharma excipients division is a premier producer of high‑purity polyethylene glycols, fatty alcohols and specialty bases for pharmaceutical and personal‑care productschemicals.sasol.com.
- Key Products Available Through Target: LIPOXOL MED PEGs; NACOL and NAFOL fatty alcoholschemicals.sasol.com; GALENOL 1618 AE P self‑emulsifying base; ISOFOL 20 P (C20 Guerbet alcohol)chemicals.sasol.com.
- Primary Applications: Ointments, creams, lotions, tablets, suppositories and topical gels in pharmaceuticals and cosmetics.
- Differentiators / Why It Matters: High purity and consistent molecular weight distribution; the self‑emulsifying base simplifies topical formulation and enhances stability.
- Sustainability / Innovation Highlights: Manufactured to GMP and pharmacopoeial standards; research into greener solvent systems and improved bioavailability.
- Value Proposition for Customers: Target delivers high‑quality excipients with technical support to improve solubility, stability and patient compliance, ensuring regulatory compliance and shorter development times.
